Alaraajojen valtimonkovetustautia sairastavien terveyteen liittyvä elämänlaatu sekä hoitomenetelmien kustannukset

The purpose of this study was to describe and investigate the health-related quality of life of patients suffering from lower limb arteriosclerotic disease before and after treatment. In addition, patients’ experiences of living with their illness were examined a year after treatment, and the costs of treatment were investigated before and after treatment. A total of 180 patients took part in the study; 64 were treated conservatively, 85 endovascularly and 31 surgically. During the study, the health-related quality of life of the patients (N = 180) was monitored at the beginning of the study and 6 and 12 months after treatment using the Nottingham Health Profile (NHP) and the 15D quality of life scale. Theme interviews were conducted with some of the patients (n = 18) a year after treatment. In addition, the costs of different treatment methods were examined using a questionnaire which mapped the patients’ (n = 153) use of health and social services and the hospital’s municipal billing data. The patients’ (N = 180) ankle-brachial systolic blood pressure ratio (ABI) was measured at the beginning of the study and 12 months after treatment. The data were analysed using basic statistical methods and content analysis. Compared to the age-and-gender-standardised normal population, the health-related quality of life of women (n = 62) suffering from lower limb arteriosclerotic disease was significantly poorer only in the dimension of pain. Prior to treatment, men’s (n = 118) health-related quality of life was significantly lower than that of other Finnish men of the same age (N = 2 126) in all the areas of the NHP scale. In addition, as measured on the 15D scale, the patients’ health-related quality of life was statistically significantly poorer compared to normal population (N = 4 048). The claudication distance and the ABI index of patients treated with endovascular and surgical methods was significantly improved one year after treatment. The quality of sleep and emotional reactions of patients treated with ...